<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-pharmaceutics-13-00379">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sakurada</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Mizoguchi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kuwahata</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Katsuyama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Komatsu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Morrone</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Corasaniti</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Bagetta</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism</article-title>
  <source>Pharmacol. Biochem. Behav.</source>
  <year>2011</year>
  <volume>97</volume>
  <fpage>436</fpage>
  <lpage>443</lpage>
  <pub-id pub-id-type="doi">10.1016/j.pbb.2010.09.020</pub-id>
  <?supplied-pmid 20932858?>
  <pub-id pub-id-type="pmid">20932858</pub-id>
 </element-citation>
</ref>
